Table 1.

Incidences of Brevundimonas spp. infection from 1978–2000 – Main characteristics of the case reports.

Author (Ref)/ Species	Year	Sex/Age	Country	Co-morbidity	Type of infection	Susceptible to	Resistance to	Antibiotic treatment	Outcome
Otto et al. [53], B. vesicularis	1978	Multiple cases (5 cases)	USA	N/A	Cervicitis	Ampicillin, Carbenicillin, Gentamicin, Kanamycin Nitrofurantoin, Streptomycin, Tetracycline	Colistin, Nalidixic acid, Sulfisoxazole	N/A	N/A
Vanholder et al. [54], B. vesicularis	1990	M/62	Belgium	Hemodialysis,	Bacteraemia/HA	N/A	N/A	Cefotaxime, Tobramycin	Complete recovery
Vanholder et al. [55], B. vesicularis	1992	F/62	Belgium	Hemodialysis,	Bacteraemia/HA	N/A	N/A	Cefotaxime, Tobramycin	Complete recovery
Planes et al. [56], B. vesicularis	1992	W/54	USA	Systemic lupus erythematosus and chronic active autoimmune hepatitis	Bacteraemia/HA	N/A	N/A	Ceftazidime, Tobramycin	Surgical resection of the infected tissue
Pasadakis et al. [57], B. diminuta	1993	N/A	Greece	End-stage renal failure	Peritonitis	N/A	N/A	Initial 500 mg/L ceftazidime in a I-L + 1.7 mg/kg of tobramycin. Maintenance doses 250 mg/2 L of ceftazidime + 16 mg/2 L of tobramycin	Complete recovery
Oberhelman et al. [58], B. vesicularis	1994	M/5	USA	Sickle cell anaemia	Pneumonia/CA	N/A	N/A	Ceftriaxone, Gentamicin	Complete recovery
Calegari et al. [59], B. vesicularis	1996	M/60	Uruguay	Trauma	Botryomycosis/CA	N/A	N/A	Cefuroxime	Complete recovery
Gilad et al. [60], B. vesicularis	2000	F/42	Israel	Mitral valve replacement	Bacteraemia/HA	Amoxicillin-Clavulanate, Amino-glycosides, Co-trimoxazole, Imipenem, Mezlocillin, Piperacillin, Piperacillin- Tazobactam	Ampicillin, Aztreonam, Cefuroxime, Ceftriaxone, Ceftazidime, Ciprofloxacin	Piperacillin- Tazobactam	Complete recovery

M- Male, F- Female, N/A – Not Available, CA – Community Acquired, HA- Hospital Acquired.